S1PR1-ECKO mice treated with K/BxN serum showed more severe arthritis measured by clinical score and more inflammation and joint damage assessed histologically compared with tamoxifen-treated littermate controls (S1PR1fl/fl) (Figure 1, D and E). This evidence concerns the gene S1PR1 and arthritic joint disease.